Table 3 Operational impact of Coronavirus disease 2019 (COVID-19) pandemic

From: Impact of a pandemic on surgical neuro-oncology—maintaining functionality in the early phase of crisis

Variable Number of hospitals (%)
Criteria for performing neurosurgery
 Only emergency surgery in COVID-19-negative patients (diagnosed by imaging and laboratory examination) 5 (3.5)
 Only emergency surgery in COVID-19-negative patients (diagnosed by clinical manifestation and imaging) 2 (1.4)
 Only emergency surgery (regardless of COVID-19 status) 16 (11.1)
 Neurosurgery in only COVID-19-negative patients (diagnosed by imaging and laboratory examination) 44 (30.6)
 Neurosurgery in only COVID-19-negative patients (diagnosed by clinical manifestation and imaging) 53 (36.8)
 Other criteria 15 (10.4)
Emergency neurosurgery status
 No emergency surgery 9 (6.3)
 Only for COVID-negative patients 52 (36.1)
 Emergency surgery performed routinely 83 (57.6)
Elective neuro-oncological surgery status
 No elective surgery 52 (36.1)
 Only for COVID-negative patients 74 (51.4)
 Elective surgery performed routinely 18 (12.5)
Protocols to restrict visitors to neurosurgery department 141 (97.9)
Discussion of ethical issues concerning how decisions will be made in the event healthcare resources must be prioritized and allocated 122 (84.7)
Patient follow-up for discharged patients
 In-person 10 (6.9)
 Telehealth 27 (18.8)
 Phone call 107 (74.3)
 Mobile nurses 0 (0%)
Anticipation that the current COVID-19 pandemic will be contained in the upcoming weeks 124 (86.1)
Assessment of how soon operating restrictions might be lifted
  < 1 month 36 (25.0)
 1–3 months 100 (69.4)
 3–6 months 3 (2.1)
  > 6 months 1 (0.7)
Anticipation of COVID-19-related disruption to neurosurgery department supplies
 Little or no disruption 61 (42.4)
 Moderate disruption 70 (48.6)
 Severe disruption 13 (9.0)
Anticipation of further COVID-19-related re-allocation of personnel from neurosurgery department
 Little or none 116 (80.6)
 Moderate 26 (18.1)
 Extensive 2 (1.4)